Greenwich Lifesciences had a nice pop today and is currently up 8.81% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.
The company isn't at an immediate support or resistance level that might be predictive. Greenwich Lifesciences hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. GLSI might find some support at the 21.65 level, buyers might push the price back up from here. But it's not very clear what will happen.